Aibotics Inc

Discover how Aibotics Inc. is reshaping AI and robotics with its joint venture with ARYA AI Labs and the production of PHILL™ service robots—blending deterministic AI, biotech, and advanced manufacturing for next‑gen solutions.

Aibotics Inc. delays its 2026 10‑Q filing for extra audit review, yet CEO Ben Kaplan reassures investors that operations remain steady while the company advances plant‑based neurological therapies.

Aibotics Inc., a biotechnology company, is developing innovative therapies for neurological disorders using plant-based compounds and advanced molecular biology techniques, with a mission to improve patient outcomes and quality of life.